| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.38 | 2e-11 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.37 | 4e-10 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | 0.18 | 5e-07 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.24 | 1e-06 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | 0.16 | 3e-06 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.22 | 4e-06 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0002 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0003 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.0003 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0004 |